BridgeBio Pharma Inc (NAS:BBIO)
$ 27.94 0.18 (0.65%) Market Cap: 5.23 Bil Enterprise Value: 6.44 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 48/100

BridgeBio Pharma Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 04:15PM GMT
Release Date Price: $38.74 (+2.79%)
Anupam Rama
J.P. Morgan Securities LLC - Analyst

Welcome, everyone, to the 42nd Annual J.P. Morgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at J.P. Morgan. I'm joined by my squad, [Laurea] Hall, Priyanka Grover, Malcolm Kuno.

Our next presenting company is BridgeBio. And presenting on behalf of the company, we have CEO, Neil Kumar. Neil?

Neil Kumar
BridgeBio Pharma Inc - Chief Executive Officer, Director

Thanks so much, Anupam. Thanks to the squad and the entire J.P. Morgan team, including Phil Ross, for having us here again. We've been privileged to present here seven of the eight years we've been around as a company, and we've been through some ups and downs with all of you in this room. And I finally feel like we've arrived at the beginning, really a starting line, if you will.

And what I want to talk about for the next 25 minutes or so is how we intend to come out of that starting block to develop and to create a fully integrated pharmaceutical company that can serve patients with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot